Mammography Market, By Product Type (Digital Systems, Analog Systems, Film Screen Systems, and Others), By Technology (Breast Tomosynthesis, CAD Mammography, and Digital Mammography), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, and Othe

Mammography Market, By Product Type (Digital Systems, Analog Systems, Film Screen Systems, and Others), By Technology (Breast Tomosynthesis, CAD Mammography, and Digital Mammography), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


The global mammography market has witnessed substantial growth over the past few years owing to the rising prevalence of breast cancer worldwide. Breast cancer is one of the leading causes of cancer-related deaths among women. According to the World Health Organization (WHO), it was stated that around 2 million new cases of breast cancer were diagnosed in 2020. Early detection is crucial as it can significantly improve the chances of successful treatment. Mammography allows doctors to detect tumors that cannot be felt during a physical exam and may be too small to see or feel. It provides a detailed view of the inside of the breast and helps identify any abnormalities, which has contributed to the growing adoption of mammography screening across various countries. Advancements in digital mammography technologies have further augmented the market growth.

Market Dynamics:

The global mammography market is primarily driven by the rising incidence of breast cancer, growing public awareness regarding early cancer detection, favorable government initiatives to promote screening programs, and technological advancements. According to the American Cancer Society, there were around 1.4 million newly diagnosed breast cancer cases in 2021. Early detection through mammography screening can detect cancer at an early stage when treatment is most effective. Various governments also support routine screening. However, the high cost of mammography systems, lack of awareness in low-income countries, and disadvantages of radiation exposure associated with mammograms are some of the factors hindering the market growth. Meanwhile, ongoing technological upgrades such as 3D mammography, whole-breast ultrasound, and artificial intelligence are expected to provide new opportunities for players in the mammography market.

Key Features of the Study:
  • This report provides an in-depth analysis of the global mammography market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global mammography market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study Carestream Health, Siemens Healthineers, Planmed Oy, Konica Minolta Inc., Metaltronica SpA, Koninklijke Philips N.V., General Medical Merate SpA, Hologic Inc., GE Healthcare, Fujifilm Holdings Corporation, Analogic Corporation, Canon Medical Systems Corporation, and Toshiba Medical Systems.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global mammography market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mammography market.
Detailed Segmentation-
  • By Product Type:
  • Digital Systems
  • Analog Systems
  • Film Screen Systems
  • Others
  • By Technology:
  • Breast Tomosynthesis
  • CAD Mammography
  • Digital Mammography
  • By End User:
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Others
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • Carestream Health
  • Siemens Healthineers
  • Planmed Oy
  • Konica Minolta Inc.
  • Metaltronica SpA
  • Koninklijke Philips N.V.
  • General Medical Merate SpA
  • Hologic Inc.
  • GE Healthcare
  • Fujifilm Holdings Corporation
  • Analogic Corporation
  • Canon Medical Systems Corporation
  • Toshiba Medical Systems


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Disorder Type
Market Snapshot, By Drug Type
Market Snapshot, By Route of Administration
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Pipeline Analysis
Epidemiology
Pricing and Brand Analysis
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Pigmentation Disorders Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the market
5. Global Pigmentation Disorders Treatment Market, By Disorder Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Melasma
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Vitiligo
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Albinism
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Post-Inflammatory Hyperpigmentation (PIH)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Pigmentation Disorders Treatment Market, By Drug Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Corticosteroids
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Calcineurin Inhibitors
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Janus kinase (JAK) inhibitor
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Melanin Synthesis Inhibitor
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Pigmentation Disorders Treatment Market, By Route of Administration, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Oral
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Topical
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Pigmentation Disorders Treatment Market, By Distribution Channel, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
9. Global Pigmentation Disorders Treatment Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Regions, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Abbvie Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Edesa Biotech, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Amgen, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
CLINUVEL PHARMACEUTICALS LTD
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Uniza Group
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Dr. Reddy’s Laboratories Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Roivant Sciences Ltd.
Incyte
Aclaris Therapeutics, Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Market Strategies
Viatris Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
GSK plc.
Vyne Therapeutics Inc.
Temprian Therapeutics Inc.
Arrien Pharmaceuticals, LLC
11. Analyst View
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 30 figures on Pigmentation Disorders Treatment Market” -Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings